Versant Voyageurs I Parallel, L.P., 10% Owner at Black Diamond Therapeutics, Inc. (BDTX), sold 8,435 shares at $33.09 ($279K) on 2020-11-18, disclosed to the SEC on 2020-11-19.
Scheduled sale ($279k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.05 | 489 | $16K | 5.8% |
| 2 | $33.05 | 3,705 | $122K | 43.9% |
| 3 | $33.05 | 3,705 | $122K | 43.9% |
| 4 | $33.09 | 63 | $2K | 0.7% |
| 5 | $33.09 | 473 | $16K | 5.6% |
| Total | $33.05 avg | 8,435 |
| $279K |
| 100% |
| Filing → |
| BDTX | SELL | 2020-10-20 | $992K | — | Filing → |
| BDTX | SELL | 2020-10-15 | $1.1M | — | Filing → |
| BDTX | SELL | 2020-10-13 | $1.4M | — | Filing → |